Mastaplex 200 mg

Mastaplex 200 mg contains drostanolone enanthate, an injectable anabolic steroid. Historically, it was approved for treating inoperable breast cancer in women but is no longer manufactured for clinical use. In non-medical bodybuilding contexts, it is commonly referenced during cutting phases for muscle hardening and anti-estrogenic effects, though such use falls outside approved indications.

Drostanolone enanthate has a half-life of approximately 7–10 days, which supports less frequent administration than the propionate ester. In non-medical contexts, it is typically referenced as being administered once or twice weekly to maintain stable blood levels. This is distinct from medically supervised dosing, which is individualized by a clinician.

Yes. Drostanolone enanthate suppresses the hypothalamic-pituitary-gonadal axis, and post-cycle therapy is commonly recommended after a cycle. Agents such as Clomiplex or Tamoxiplex are commonly referenced for this purpose. Due to the long enanthate ester, PCT should typically begin approximately 2 weeks after the final injection to allow for ester clearance.

Drostanolone enanthate binds to androgen receptors in muscle tissue, promoting muscle growth and fat loss while resisting metabolic breakdown. It is a modified form of dihydrotestosterone with a methyl group at carbon-2 alpha that increases its anabolic strength. It does not aromatize to estrogen, contributing to its reputation for producing a hard, dry physique appearance.

In bodybuilding discussions, the anti-estrogenic effects of drostanolone enanthate become apparent around weeks 3–4, with reduced water retention and a visibly tighter midsection if body fat is reasonably low. Early signs of muscle hardness and improved vascularity begin to appear in lean individuals during this period. Full steady-state effects for the enanthate ester are typically reached by weeks 8–12.

There is no universally "best" injectable for cutting. Drostanolone enanthate is commonly referenced for its hardening and anti-estrogenic effects, but Primoplex (methenolone) and Testaplex P 100 (testosterone propionate) are also widely discussed. The appropriate choice depends on individual goals, body fat levels, and tolerance for androgenic side effects.

Both are drostanolone esters, but they differ in release rate. Drostanolone enanthate has a half-life of approximately 7–10 days, supporting less frequent administration. Drostanolone propionate has a shorter half-life of approximately 2–3 days, requiring more frequent injections. Axiolabs offers Mastaplex 100 as its drostanolone propionate product.

Both are DHT-derived compounds used in cutting phases, but they have different profiles. Drostanolone is generally considered more aggressive for producing a hard, dry look with strong anti-estrogenic properties, while Primobolan (methenolone) is often described as milder and more sustainable. Axiolabs offers Primoplex as its methenolone product.

In non-medical bodybuilding contexts, 400 mg per week is within the commonly referenced range of 200–600 mg per week, typically at the intermediate level. Mastaplex 200 mg contains 200 mg/mL, so 400 mg would equal 2 mL per week. Dosage appropriateness depends on individual factors and the overall cycle context.

Mastaplex 200 mg is labeled at 200 mg of drostanolone enanthate per mL. It is supplied in a 10 mL vial, giving 2,000 mg of total labeled drostanolone enanthate content per vial.

Lab testing information for Mastaplex 200 mg is not available on this page. For product-specific testing inquiries, please contact customer support.

Yes. As a DHT-derived compound, drostanolone enanthate can accelerate hair loss in individuals with a genetic predisposition to male pattern baldness. Finasteride will not help because it targets 5-alpha reductase, which does not affect DHT derivatives. If you are already experiencing hair thinning, drostanolone may accelerate the process.